Alethea Capital Management, LLC Kura Oncology, Inc. Transaction History

Alethea Capital Management, LLC

$155 Million
Q3 2025

A detailed history of Alethea Capital Management, LLC transactions in Kura Oncology, Inc. stock. As of the latest transaction made, Alethea Capital Management, LLC holds 150,000 shares of KURA stock, worth $1.68 Million. This represents 0.85% of its overall portfolio holdings.

Number of Shares

150,000

Previous 949,285 84.2%

Holding current value

$1.68 Million

Previous $5.48 Million 75.77%

% of portfolio

0.85%

Previous 4.4%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 14, 2025	BUY	$5.54 - $9.05 $2.43 Million - $3.98 Million	439,509 Added 46.3%	1,388,794 $12.3 Million
Q2 2025 Aug 14, 2025	BUY	$5.55 - $6.92 $1.61 Million - $2.01 Million	290,108 Added 44.01%	949,285 $5.48 Million
Q1 2025 May 14, 2025	BUY	$6.6 - $9.05 $664,851 - $911,651	100,735 Added 18.04%	659,177 $4.35 Million
Q4 2024 Feb 14, 2025	BUY	$8.51 - $19.21 $41,699 - $94,129	4,900 Added 0.89%	558,442 $4.86 Million
Q3 2024 Nov 14, 2024	BUY	$18.57 - $23.23 $5.34 Million - $6.68 Million	287,636 Added 108.17%	553,542 $10.8 Million

Q2 2024 Aug 15, 2024	BUY	$17.53 - $22.98 $110,439 - $144,774	6,300 Added 2.43%	265,906 $5.48 Million
Q1 2024 May 15, 2024	SELL	$13.42 - $23.53 $1.22 Million - $2.14 Million	-90,839 Reduced 25.92%	259,606 $5.54 Million
Q3 2023 Nov 14, 2023	BUY	$8.44 - $11.86 $143,480 - $201,620	17,000 Added 5.1%	350,445 $3.2 Million
Q2 2023 Aug 14, 2023	SELL	$9.62 - $13.99 $291,755 - $424,288	-30,328 Reduced 8.34%	333,445 $3.53 Million
Q4 2022 Feb 14, 2023	SELL	$11.23 - $16.9 $31,399 - $47,252	-2,796 Reduced 0.76%	363,773 $4.51 Million
Q2 2022 Aug 15, 2022	BUY	$10.71 - $18.33 $95,843 - $164,035	8,949 Added 2.5%	366,569 $6.72 Million
Q1 2022 May 13, 2022	BUY	$11.78 - $16.98 $3.2 Million - $4.62 Million	271,820 Added 316.81%	357,620 $5.75 Million
Q4 2021 Feb 14, 2022	BUY	$12.22 - $19.57 $1.05 Million - $1.68 Million	85,800 New	85,800 $1.2 Million
Q1 2021 May 14, 2021	SELL	$24.75 - $39.14 $1.67 Million - $2.64 Million	-67,568 Closed	0 $0
Q4 2020 Feb 12, 2021	SELL	$29.0 - $41.62 $1.39 Million - $2 Million	-48,073 Reduced 41.57%	67,568 $2.21 Million
Q3 2020 Nov 16, 2020	SELL	$16.3 - $30.64 $1.64 Million - $3.08 Million	-100,530 Reduced 46.5%	115,641 $3.54 Million
Q2 2020 Aug 11, 2020	SELL	$7.95 - $18.81 $817,426 - $1.93 Million	-102,821 Reduced 32.23%	216,171 $3.52 Million
Q1 2020 May 11, 2020	BUY	$6.45 - $14.04 $338,399 - $736,608	52,465 Added 19.68%	318,992 $3.17 Million
Q2 2019 Aug 12, 2019	BUY	$14.71 - $19.79 $406,157 - $546,421	27,611 Added 11.56%	266,527 $5.25 Million
Q1 2019 May 06, 2019	BUY	$13.73 - $16.87 $290,609 - $357,070	21,166 Added 9.72%	238,916 $3.96 Million
Q4 2018 Jan 23, 2019	BUY	$10.6 - $17.49 $22,132 - $36,519	2,088 Added 0.97%	217,750 $3.06 Million
Q2 2018 Jul 17, 2018	BUY	$14.8 - $18.8 $518,991 - $659,259	35,067 Added 19.42%	215,662 $3.93 Million
Q1 2018 Apr 18, 2018	BUY	$14.5 - $23.4 $1.32 Million - $2.13 Million	90,922 Added 101.39%	180,595 $3.39 Million
Q4 2017 Feb 14, 2018	SELL	$13.5 - $16.65 $297,000 - $366,299	-22,000 Reduced 19.7%	89,673 $1.37 Million
Q3 2017 Nov 02, 2017	BUY	$6.05 - $14.95 $675,621 - $1.67 Million	111,673	111,673 $1.67 Million

Others Institutions Holding KURA

# of Institutions

212

Shares Held

81.4M

Call Options Held

900K

Put Options Held

228K

View Full List

About Kura Oncology, Inc.

Ticker KURA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 66,893,000
Market Cap $749M
Description
Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer in the United States. The company's pipeline consists of small molecule product candidates that target cancer. Its lead product candidates are ziftomenib, a small molecule inhibitor of the menin-Lysine K-specific Methyltransferase 2A p...

More about KURA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Alethea Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Alethea Capital Management, LLC with notifications on news.

Account

Alethea Capital Management, LLC Kura Oncology, Inc. Transaction History